Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2020; 19: 22-29
Трансплантация гемопоэтических стволовых клеток у детей в России: краткий обзор активности в 2015–2018 гг.
https://doi.org/10.24287/1726-1708-2020-19-2-22-29Аннотация
Трансплантация гемопоэтических стволовых клеток (ТГСК) у детей – специализированная высокотехнологичная область медицины, объединяющая последние достижения детской гематологии, онкологии, иммунологии, трансфузиологии, молекулярной биологии и клеточной терапии. Успех ТГСК во многом связан с уникальным опытом международной и национальной кооперации между трансплантационными центрами. Одним из важнейших компонентов такой кооперации является совместный регулярный анализ трансплантационной активности, направленный на выявление трендов и проблем, требующих теоретического и практического разрешения. Настоящая работа суммирует опыт выполнения ТГСК во всех крупнейших педиатрических центрах России за период 2015–2018 гг.
Список литературы
1. Duarte R.F., Labopin M., Bader P., Basak G.W., Bonini C., Chabannon C., et al. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019; 54 (10):1525–52. DOI: 10.1038/s41409-019-0516-2
2. Passweg J.R., Baldomero H., Bader P., Basak G.W., Bonini C., Duarte R., et al. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018; 53 (9): 1139–48. DOI: 10.1038/s41409-018-0153-1
3. Passweg J.R., Baldomero H., Bader P., Bonini C., Cesaro S., Dreger P., et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016; 51 (6): 786–92. DOI: 10.1038/bmt.2016.20
4. Passweg J.R., Baldomero H., Bader P., Bonini C., Duarte R.F., Dufour С., et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017; 52 (6): 811–7. DOI: 10.1038/bmt.2017.34
5. Passweg J.R., Baldomero H., Basak G.W., Chabannon C., Corbacioglu S., Duarte R., et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 2019; 54 (10): 1575–85. DOI: 10.1038/s41409-019-0465-9
6. Passweg J.R., Baldomero H., Chabannon C., Chabannon C., Corbacioglu S., Duarte R., et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus. Bone Marrow Transplant. 2020 DOI: 10.1038/s41409-020-0826-4
Pediatric Hematology/Oncology and Immunopathology. 2020; 19: 22-29
Hematopoietic stem cell transplantation in children in Russia: a brief overview of activity in 2015–2018
https://doi.org/10.24287/1726-1708-2020-19-2-22-29Abstract
Hematopoietic stem cell transplantation (HSCT) in children is a high-tech field of medicine that combines the latest achievements of pediatric hematology, oncology, immunology, transfusiology, molecular biology and cell therapy. The success of HSCT is largely owing to the unique experience of international and national cooperation between transplant centers. A regular joint analysis of transplantation activity, focused on identifying trends and problems that require theoretical and practical solutions, is one of the most important components of such cooperation. The present work summarizes the experience of HSCT in all major pediatric centers in Russia for the period 2015–2018.
References
1. Duarte R.F., Labopin M., Bader P., Basak G.W., Bonini C., Chabannon C., et al. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019; 54 (10):1525–52. DOI: 10.1038/s41409-019-0516-2
2. Passweg J.R., Baldomero H., Bader P., Basak G.W., Bonini C., Duarte R., et al. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018; 53 (9): 1139–48. DOI: 10.1038/s41409-018-0153-1
3. Passweg J.R., Baldomero H., Bader P., Bonini C., Cesaro S., Dreger P., et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016; 51 (6): 786–92. DOI: 10.1038/bmt.2016.20
4. Passweg J.R., Baldomero H., Bader P., Bonini C., Duarte R.F., Dufour S., et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017; 52 (6): 811–7. DOI: 10.1038/bmt.2017.34
5. Passweg J.R., Baldomero H., Basak G.W., Chabannon C., Corbacioglu S., Duarte R., et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 2019; 54 (10): 1575–85. DOI: 10.1038/s41409-019-0465-9
6. Passweg J.R., Baldomero H., Chabannon C., Chabannon C., Corbacioglu S., Duarte R., et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus. Bone Marrow Transplant. 2020 DOI: 10.1038/s41409-020-0826-4
